Product Images Advair Diskus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Advair Diskus NDC 50090-4502 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fluticasone propionate chemical structure - advair diskus spl graphic 01

Fluticasone propionate chemical structure - advair diskus spl graphic 01

Salmeterol xinafoate chemical structure - advair diskus spl graphic 02

Salmeterol xinafoate chemical structure - advair diskus spl graphic 02

Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03

Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03

Not available.*

S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04

S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04

Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05

Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05

Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06

Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06

Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07

Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07

Figure A - advair diskus spl graphic 08

Figure A - advair diskus spl graphic 08

Not available*

Figure B - advair diskus spl graphic 09

Figure B - advair diskus spl graphic 09

Figure C - advair diskus spl graphic 10

Figure C - advair diskus spl graphic 10

Figure D - advair diskus spl graphic 11

Figure D - advair diskus spl graphic 11

Figure E - advair diskus spl graphic 12

Figure E - advair diskus spl graphic 12

Figure F - advair diskus spl graphic 13

Figure F - advair diskus spl graphic 13

Figure G - advair diskus spl graphic 14

Figure G - advair diskus spl graphic 14

Figure H - advair diskus spl graphic 15

Figure H - advair diskus spl graphic 15

Label Image - lbl500904502

Label Image - lbl500904502

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.